QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics

Olga Lomovskaya(Mapp Biopharmaceutical (United States)), Michael Dudley(Mapp Biopharmaceutical (United States))
Frontiers in Microbiology
July 5, 2021
Cited by 48


Related Papers

Tackling antibiotic resistance
|Nature Reviews Microbiology|2011|1.1k